Desjardins Global Asset Management Inc. Has $158,000 Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Desjardins Global Asset Management Inc. trimmed its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 11.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,037 shares of the company’s stock after selling 267 shares during the quarter. Desjardins Global Asset Management Inc.’s holdings in GE HealthCare Technologies were worth $158,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the company. SVB Wealth LLC lifted its stake in shares of GE HealthCare Technologies by 7.5% in the fourth quarter. SVB Wealth LLC now owns 6,126 shares of the company’s stock worth $474,000 after buying an additional 425 shares during the last quarter. Capital Analysts LLC increased its position in GE HealthCare Technologies by 938.6% during the fourth quarter. Capital Analysts LLC now owns 457 shares of the company’s stock worth $35,000 after acquiring an additional 413 shares during the period. Sippican Capital Advisors increased its position in GE HealthCare Technologies by 3.4% during the fourth quarter. Sippican Capital Advisors now owns 16,891 shares of the company’s stock worth $1,306,000 after acquiring an additional 552 shares during the period. Waldron Private Wealth LLC bought a new position in GE HealthCare Technologies during the fourth quarter worth $214,000. Finally, Strs Ohio increased its position in GE HealthCare Technologies by 14.6% during the fourth quarter. Strs Ohio now owns 159,174 shares of the company’s stock worth $12,307,000 after acquiring an additional 20,333 shares during the period. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Down 0.2 %

Shares of NASDAQ GEHC opened at $84.97 on Friday. The firm’s 50-day simple moving average is $88.67 and its 200 day simple moving average is $77.70. The company has a market cap of $38.77 billion, a price-to-earnings ratio of 28.14, a price-to-earnings-growth ratio of 2.96 and a beta of 0.94. The company has a quick ratio of 0.83, a current ratio of 1.05 and a debt-to-equity ratio of 1.18. GE HealthCare Technologies Inc. has a 12-month low of $62.35 and a 12-month high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The company had revenue of $5.20 billion for the quarter, compared to the consensus estimate of $5.09 billion. During the same period last year, the company earned $1.31 earnings per share. The firm’s revenue was up 5.3% compared to the same quarter last year. On average, research analysts expect that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be issued a $0.03 dividend. The ex-dividend date is Thursday, April 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.97%.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on GEHC. Citigroup boosted their target price on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. UBS Group raised shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and boosted their price target for the company from $66.00 to $88.00 in a report on Monday, February 12th. Mizuho boosted their price target on shares of GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, April 11th. Evercore ISI boosted their price target on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a report on Thursday, April 4th. Finally, Morgan Stanley boosted their price target on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a report on Monday, February 12th. Four research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and a consensus target price of $95.08.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.